Inhibrx Biosciences (INBX) EPS (Basic) (2023 - 2025)

Inhibrx Biosciences' (INBX) quarterly EPS (Basic) came in at -$2.12 in Q4 2025, up 34.44% year-on-year from -$1.58 in Q4 2024, and up 6.92% on a QoQ basis from -$2.28 in Q3 2025.

Inhibrx Biosciences (INBX) EPS (Basic) (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of EPS (Basic) data on file, last reported at -$2.12 in Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 34.44% year-over-year to -$2.12 in Q4 2025; TTM through Dec 2025 was -$9.04, a 107.93% decrease from a year earlier, with the FY2025 full-year figure at -$9.04, down 107.93% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$2.12, up from -$2.28 in the prior quarter.
  • Over the last five years, EPS (Basic) for INBX reached as high as $127.1 in Q2 2024 and fell as low as -$7.81 in Q4 2023.
  • Historically, EPS (Basic) has averaged $8.15 across 3 years, with a median of -$2.84 in 2024.
  • Across the five-year window, EPS (Basic) jumped 3047.25% in 2024 and plunged 101.46% in 2025, its largest moves.
  • Year by year, EPS (Basic) stood at -$7.81 in 2023, then surged by 58.57% to -$3.23 in 2024, then jumped by 34.44% to -$2.12 in 2025.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$2.12 in Q4 2025, -$2.28 in Q3 2025, and -$1.85 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Inhibrx Biosciences 1.32 Bn 1.32 Bn - -2.12

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.12
Sep 30, 2025 -2.28
Jun 30, 2025 -1.85
Mar 31, 2025 -2.80
Dec 31, 2024 -3.23
Sep 30, 2024 -2.84
Jun 30, 2024 127.10
Mar 31, 2024 -5.77
Dec 31, 2023 -7.81
Sep 30, 2023 -4.39
Jun 30, 2023 -4.31